NNP
AXNX

Nachman Norwood & Parrott’s Axonics, Inc. Common Stock AXNX Stock Holding History

Nachman Norwood & Parrott’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,578
Closed -$81K – 1102
2020
Q3 		$81K Buy
+1,578
New +$65.9K 0.01% 359

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Nachman Norwood & Parrott's AXNX Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2020, closing a stake of 1,578 shares — an estimated $81K sold.

Nachman Norwood & Parrott first reported a position in AXNX in Q3 2020 and held it in 1 quarter. The position peaked at $81K in Q3 2020. 149 funds tracked by Wall St. Rank hold AXNX as of Q4 2020.

  • Nachman Norwood & Parrott reported no remaining Axonics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Nachman Norwood & Parrott sold 1,578 Axonics, Inc. Common Stock shares in Q4 2020, an estimated $81K.
  • Nachman Norwood & Parrott first reported a position in Axonics, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Nachman Norwood & Parrott's Axonics, Inc. Common Stock position peaked at $81K in Q3 2020.
  • 149 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.